Why the three biggest vaccine makers failed on Covid-19 The big three incumbents preferred to prioritise their tried and tested methods. “Companies tend to rely on their proprietary technologies because they think they can trust them — and don’t want to infringe on rivals’ intellectual property,” said Mansoor Amiji, professor of pharmaceutical sciences at Northeastern university.